Cargando…

Theranostic F-SLOH mitigates Alzheimer's disease pathology involving TFEB and ameliorates cognitive functions in Alzheimer's disease models

Accumulation of amyloid-β (Aβ) oligomers and phosphorylated Tau aggregates are crucial pathological events or factors that cause progressive neuronal loss, and cognitive impairments in Alzheimer's disease (AD). Current medications for AD have failed to halt, much less reverse this neurodegenera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iyaswamy, Ashok, Wang, Xueli, Krishnamoorthi, Senthilkumar, Kaliamoorthy, Venkatapathy, Sreenivasmurthy, Sravan G., Kumar Durairajan, Siva Sundara, Song, Ju-Xian, Tong, Benjamin Chun-kit, Zhu, Zhou, Su, Cheng-Fu, Liu, Jia, Cheung, King-Ho, Lu, Jia-Hong, Tan, Jie-Qiong, Li, Hung Wing, Wong, Man Shing, Li, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921490/ https://www.ncbi.nlm.nih.gov/pubmed/35286997 http://dx.doi.org/10.1016/j.redox.2022.102280

Ejemplares similares

Reduction of kinesin I heavy chain decreases tau hyperphosphorylation, aggregation, and memory impairment in Alzheimer’s disease and tauopathy models
por: Selvarasu, Karthikeyan, et al.
Publicado: (2022)

Real-Time Detection and Visualization of Amyloid-β Aggregates Induced by Hydrogen Peroxide in Cell and Mouse Models of Alzheimer’s Disease
por: Wang, Xueli, et al.
Publicado: (2022)

Bromo-protopine, a novel protopine derivative, alleviates tau pathology by activating chaperone-mediated autophagy for Alzheimer’s disease therapy
por: Sreenivasmurthy, Sravan Gopalkrishnashetty, et al.
Publicado: (2022)

Targeting Aggrephagy for the Treatment of Alzheimer’s Disease
por: Malampati, Sandeep, et al.
Publicado: (2020)

Celastrol enhances transcription factor EB (TFEB)-mediated autophagy and mitigates Tau pathology: Implications for Alzheimer's disease therapy
por: Yang, Chuanbin, et al.
Publicado: (2022)

A small molecule transcription factor EB activator ameliorates beta‐amyloid precursor protein and Tau pathology in Alzheimer's disease models
por: Song, Ju‐Xian, et al.
Publicado: (2019)

Klotho an Autophagy Stimulator as a Potential Therapeutic Target for Alzheimer’s Disease: A Review
por: Fung, Tsz Yan, et al.
Publicado: (2022)

A stress response p38 MAP kinase inhibitor SB202190 promoted TFEB/TFE3-dependent autophagy and lysosomal biogenesis independent of p38
por: Yang, Chuanbin, et al.
Publicado: (2020)

Mechanistic Insights into Selective Autophagy Subtypes in Alzheimer’s Disease
por: Guan, Xinjie, et al.
Publicado: (2022)

Balancing mTOR Signaling and Autophagy in the Treatment of Parkinson’s Disease
por: Zhu, Zhou, et al.
Publicado: (2019)

A Curcumin Derivative Activates TFEB and Protects Against Parkinsonian Neurotoxicity in Vitro
por: Wang, Ziying, et al.
Publicado: (2020)

Novel Insight into Functions of Transcription Factor EB (TFEB) in Alzheimer’s Disease and Parkinson’s Disease
por: Yang, Jing, et al.
Publicado: (2023)

A modified formulation of Huanglian-Jie-Du-Tang reduces memory impairments and β-amyloid plaques in a triple transgenic mouse model of Alzheimer’s disease
por: Durairajan, Siva Sundara Kumar, et al.
Publicado: (2017)

Yuan-Hu Zhi Tong Prescription Mitigates Tau Pathology and Alleviates Memory Deficiency in the Preclinical Models of Alzheimer’s Disease
por: Iyaswamy, A., et al.
Publicado: (2020)

Neurogenic Traditional Chinese Medicine as a Promising Strategy for the Treatment of Alzheimer’s Disease
por: Sreenivasmurthy, Sravan Gopalkrishnashetty, et al.
Publicado: (2017)

TFEB acetylation promotes lysosome biogenesis and ameliorates Alzheimer’s disease–relevant phenotypes in mice
por: Li, Tianyou, et al.
Publicado: (2022)

Role of Exosomes in the Pathogenesis and Theranostic of Alzheimer’s Disease and Parkinson’s Disease
por: He, Aojie, et al.
Publicado: (2023)

Nucleic Acid-Based Theranostics for Tackling Alzheimer's Disease
por: Chakravarthy, Madhuri, et al.
Publicado: (2017)

mTOR-dependent TFEB activation and TFEB overexpression enhance autophagy-lysosome pathway and ameliorate Alzheimer's disease-like pathology in diabetic encephalopathy
por: Cheng, Lizhen, et al.
Publicado: (2023)

Investigating the Theranostic Potential of Graphene Quantum Dots in Alzheimer’s Disease
por: Walton-Raaby, Max, et al.
Publicado: (2023)

A Promising Approach: Magnetic Nanosystems for Alzheimer’s Disease Theranostics
por: Chaparro, Catarina I. P., et al.
Publicado: (2023)

Fe65-engineered neuronal exosomes encapsulating corynoxine-B ameliorate cognition and pathology of Alzheimer’s disease
por: Iyaswamy, Ashok, et al.
Publicado: (2023)

Oleoylethanolamide facilitates PPARa and TFEB signaling and attenuates Ab pathology in a mouse model of Alzheimer’s disease
por: Comerota, Michele, et al.
Publicado: (2023)

Curcumin and Its Derivatives as Theranostic Agents in Alzheimer’s Disease: The Implication of Nanotechnology
por: Shabbir, Umair, et al.
Publicado: (2020)

Intermittent hypoxia therapy ameliorates beta-amyloid pathology via TFEB-mediated autophagy in murine Alzheimer's disease
por: Wang, Xueting, et al.
Publicado: (2023)

Effects of Huanglian-Jie-Du-Tang and Its Modified Formula on the Modulation of Amyloid-β Precursor Protein Processing in Alzheimer's Disease Models
por: Durairajan, Siva Sundara Kumar, et al.
Publicado: (2014)

Macrophage Targeted Theranostics as Personalized Nanomedicine Strategies for Inflammatory Diseases
por: Patel, Sravan Kumar, et al.
Publicado: (2015)

Oleoylethanolamide facilitates PPARα and TFEB signaling and attenuates Aβ pathology in a mouse model of Alzheimer’s disease
por: Comerota, Michele M., et al.
Publicado: (2023)

Editorial: Advances in Alzheimer’s disease diagnostics, brain delivery systems, and therapeutics
por: Iyaswamy, Ashok, et al.
Publicado: (2023)

Melatonin Ameliorates the Progression of Alzheimer's Disease by Inducing TFEB Nuclear Translocation, Promoting Mitophagy, and Regulating NLRP3 Inflammasome Activity
por: Fan, Li, et al.
Publicado: (2022)

MEK1/2 inhibition rescues neurodegeneration by TFEB-mediated activation of autophagic lysosomal function in a model of Alzheimer’s Disease
por: Chun, Yoon Sun, et al.
Publicado: (2022)

Systematic Review on the Efficacy and Safety of Herbal Medicines for Vascular Dementia
por: Man, Sui Cheung, et al.
Publicado: (2012)

A Novel Species of Penicillium With Inhibitory Effects Against Pyricularia oryzae and Fungal Pathogens Inducing Citrus Diseases
por: Liang, Li-Juan, et al.
Publicado: (2021)

Recent Updates on Mouse Models for Human Immunodeficiency, Influenza, and Dengue Viral Infections
por: Krishnakumar, Vinodhini, et al.
Publicado: (2019)

Tianma Gouteng Yin, a Traditional Chinese Medicine decoction, exerts neuroprotective effects in animal and cellular models of Parkinson’s disease
por: Liu, Liang-Feng, et al.
Publicado: (2015)

Corynoxine isomers decrease levels of amyloid-β peptide and amyloid-β precursor protein by promoting autophagy and lysosome biogenesis
por: Durairajan, Siva Sundara Kumar, et al.
Publicado: (2013)

Animal models for SARS-CoV-2 and SARS-CoV-1 pathogenesis, transmission and therapeutic evaluation
por: Saravanan, Udhaya Bharathy, et al.
Publicado: (2022)

Ultra-sensitive detection of protein biomarkers for diagnosis of Alzheimer’s disease
por: Chan, Hei-Nga, et al.
Publicado: (2017)

ATRI EDC: a novel cloud-native remote data capture system for large multicenter Alzheimer’s disease and Alzheimer’s disease-related dementias clinical trails
por: Jimenez-Maggiora, Gustavo A, et al.
Publicado: (2022)

Tetrandrine ameliorates cognitive deficits and mitigates tau aggregation in cell and animal models of tauopathies
por: Tong, Benjamin Chun-Kit, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d3n5va7qbnjcgadqkp9n96vbaf